- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07574372
Effect of ERAS and Upper Limb Exercise on LoS After Modified Radical Mastectomy
The Effect of Enhanced Recovery After Surgery and Upper Limb Exercise on Length of Stay After Modified Radical Mastectomy
The goal of this clinical trial is to learn if Enhanced Recovery After Surgery (ERAS) protocol and upper limb exercise shorten the length of stay (LoS) in adults after modified radical mastectomy (MRM) surgery. The main questions it aims to answer are:
• Do ERAS protocol and upper limb exercise shorten the LoS after modified radical mastectomy (MRM)? Researchers will compare the ERAS protocol and upper limb exercise intervention to standard care to determine whether these interventions reduce LoS.
Four weeks before surgery, participants in intervention group will do:
- Aerobic exercise by walking for 30 minutes at moderate intensity (Borg scale 12-14) with frequency twice a week and by cycling for 30 minutes at moderate intensity (40-60% HRR / 64-76% HRmax/RPE 12-14) with frequency three times a week.
- Strengthening exercise of lower limbs three times a week, intensity 60-80% 1RM, 3 set, 10 repetition, rest 60 seconds between sets by machine pulley.
- Strengthening exercise of upper limbs at intensity 60-80% 1RM, frequency three times a week, 10 repetition, rest 60 seconds by bench press and cable front raise.
- Stretching exercise of upper limbs and range of motion exercise frequency three times a week, hold 10 seconds, by static stretching.
After surgery, both groups will do:
• Mobilization, ambulation, and shoulder range of motion exercise in first 24 hours after surgery.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
North Sulawesi
-
Manado, North Sulawesi, Indonesia
- Prof. Dr. R. D. Kandou General Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Women aged 30-65 years
- Diagnosed with breast cancer by histopathological examination and will undergo the first MRM surgery
- Planned to undergo neoadjuvant chemotherapy
- Hemodynamically stable (assessed by vital signs)
- Mini Mental State Examination (MMSE) score > 25
- Comorbid diseases are controlled
- Corrected nutritional status
- No balance or coordination disorders
- Normal or corrected vision function
- Normal hearing function as tested by whisper test
- Willing and agree to participate in the study until completion and sign informed consent
Exclusion Criteria:
- Presence of distant metastasis
- Presence of lymphedema
- Limited joint range of motion
- Other cardiovascular conditions that contraindicate physical exercise according to the American College of Sports Medicine (ACSM) guidelines
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Standard Care
|
|
|
Eksperimentell: ERAS protocol and upper limb exercises
|
Four weeks before surgery, participants in intervention group will do:
Four weeks before surgery, participants in intervention group will do:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Length of Stay
Tidsramme: From the date of surgery until hospital discharge, assessed up to 10 days
|
Length of stay after Modified Radical Mastectomy
|
From the date of surgery until hospital discharge, assessed up to 10 days
|
Samarbeidspartnere og etterforskere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 200/EC/KEPK-KANDOU/X/2024
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .